Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 6 | $0.22 | $0.26 | $0.24 |
| Q2 2025 | 8 | $0.40 | $0.45 | $0.42 |
| Q3 2025 | 6 | $0.44 | $0.50 | $0.47 |
| Q4 2025 | 6 | $0.47 | $0.62 | $0.54 |
| Q1 2026 | 4 | $0.28 | $0.35 | $0.32 |
| Q2 2026 | 1 | $0.52 | $0.56 | $0.54 |
| Q3 2026 | 1 | $0.63 | $0.67 | $0.65 |
| Q4 2026 | 1 | $0.57 | $0.61 | $0.59 |
| Q1 2027 | 1 | $0.39 | $0.41 | $0.40 |
| Q2 2027 | 1 | $0.59 | $0.63 | $0.61 |
| Q3 2027 | 1 | $0.71 | $0.77 | $0.73 |
| Q4 2027 | 1 | $0.58 | $0.62 | $0.59 |
Pediatrix Medical Group, Inc. last posted its earnings results on Monday, November 3rd, 2025. The company reported $0.67 earnings per share for the quarter, topping analysts' consensus estimates of $0.46 by $0.21. The company had revenue of 492.88 M for the quarter and had revenue of 2.01 B for the year. Pediatrix Medical Group, Inc. has generated $-1 earnings per share over the last year ($-1.19 diluted earnings per share) and currently has a price-to-earnings ratio of 11.63. Pediatrix Medical Group, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 3rd, 2025 based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/03/2025 | Q3 2025 | $0.46 | $0.85 | 0.39 | $476.44 M | $492.88 M |
| 08/05/2025 | Q2 2025 | $0.42 | $0.45 | 0.03 | $464.37 M | $468.84 M |
| 05/06/2025 | Q1 2025 | $0.25 | $0.24 | -0.01 | N/A | $458.36 M |
| 02/20/2025 | Q4 2024 | $0.37 | $0.35 | -0.02 | N/A | $502.36 M |
| 11/01/2024 | Q3 2024 | $0.37 | $0.23 | -0.14 | $498.87 M | $511.16 M |
| 08/06/2024 | Q2 2024 | $0.31 | -$1.84 | -2.15 | $505.49 M | $504.30 M |
| 05/07/2024 | Q1 2024 | $0.18 | $0.05 | -0.13 | N/A | $495.10 M |
| 02/20/2024 | Q4 2023 | $0.32 | -$1.48 | -1.8 | N/A | $496.44 M |
| 11/02/2023 | Q3 2023 | $0.43 | $0.26 | -0.17 | $507.59 M | $506.61 M |
| 08/03/2023 | Q2 2023 | $0.40 | $0.34 | -0.06 | $495.88 M | $500.58 M |
| 05/02/2023 | Q1 2023 | $0.22 | $0.17 | -0.05 | $490.75 M | $491.01 M |
| 02/17/2023 | Q4 2022 | $0.49 | $0.36 | -0.13 | $501.97 M | $513.84 M |
| 11/03/2022 | Q3 2022 | $0.55 | $0.37 | -0.18 | $511.75 M | $489.92 M |
| 08/04/2022 | Q2 2022 | $0.47 | $0.32 | -0.15 | $491.51 M | $486.03 M |
| 04/28/2022 | Q1 2022 | $0.27 | -$0.25 | -0.52 | $474.21 M | $482.23 M |
| 02/17/2022 | Q4 2021 | $0.44 | $0.55 | 0.11 | $483.85 M | $498.53 M |
| 10/28/2021 | Q3 2021 | $0.42 | $0.36 | -0.06 | $480.30 M | $492.95 M |
| 08/06/2021 | Q2 2021 | $0.32 | $0.41 | 0.09 | $453.17 M | $472.96 M |
| 05/07/2021 | Q1 2021 | $0.13 | $0.21 | 0.08 | $426.78 M | $446.75 M |
| 02/18/2021 | Q4 2020 | $0.31 | -$0.75 | -1.06 | $458.34 M | $416.63 M |
Pediatrix Medical Group, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 3rd, 2025 based offlast year's report dates.
In the previous quarter, Pediatrix Medical Group, Inc. (:MD) reported $0.67 earnings per share (EPS) to beat the analysts' consensus estimate of $0.46 by $0.21.
The conference call for Pediatrix Medical Group, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Pediatrix Medical Group, Inc.'s latest earnings report can be read online.
Pediatrix Medical Group, Inc. (:MD) has a recorded annual revenue of $2.01 B.
Pediatrix Medical Group, Inc. (:MD) has a recorded net income of $-99,069,000.Pediatrix Medical Group, Inc. has generated $-1.19 earnings per share over the last four quarters.
Pediatrix Medical Group, Inc. (:MD) has a price-to-earnings ratio of 11.63 and price/earnings-to-growth ratio is 0.24.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED